- Home
- MNPR vs BRBI Comparison
MNPR vs BRBI Comparison
Compare MNPR & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNPR | BRBI |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.0M | 394.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNPR | BRBI |
|---|---|---|
| Price | $56.62 | $15.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $101.42 | N/A |
| AVG Volume (30 Days) | ★ 305.3K | 6.7K |
| Earning Date | 11-13-2025 | 02-10-2026 |
| Dividend Yield | N/A | ★ 5.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.31 |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20.80 |
| P/E Ratio | ★ N/A | $12.68 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.06 | $12.15 |
| 52 Week High | $105.00 | $67.01 |
Technical Indicators
Market Signals| Indicator | MNPR | BRBI |
|---|---|---|
| Relative Strength Index (RSI) | 35.02 | 55.10 |
| Support Level | $60.00 | $13.88 |
| Resistance Level | $67.34 | $16.61 |
| Average True Range (ATR) | 4.84 | 0.70 |
| MACD | -0.92 | 0.11 |
| Stochastic Oscillator | 5.84 | 63.29 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About BRBI BRBI BR Partners S.A. ADSs
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.